MDAI Spectral AI, Inc.
Price Chart
Executive Summary
Spectral AI (MDAI) announced $31.7 million in additional non-dilutive funding from BARDA to advance development of its DeepView® System, an AI-powered burn wound imaging technology. The funding accelerates Phase II development, including total body surface area mapping, and supports FDA clearance efforts. The company is also contributing $9.7 million to the project, which is part of a larger contract valued up to $150 million.
Key Financial Metrics
Actionable Insight
This funding de-risks the path to FDA authorization and commercialization of the DeepView System. Traders should monitor for upcoming FDA decision timelines and potential near-term catalysts. The non-dilutive nature of the funding is a positive signal for shareholders, avoiding near-term equity dilution.
Key Facts
- Spectral AI received $31.7 million in new non-dilutive funding from BARDA.
- Company committed to contribute an additional $9.7 million to development costs.
- Total BARDA contract value remains up to $150 million, with $54.9 million previously committed and now $31.7 million newly advanced.
- Funding supports FDA clearance and development of DeepView System, including total body surface area mapping.
- DeepView System targets use in emergency departments, trauma centers, and as a medical countermeasure for mass burn incidents.
Financial Impact
$31.7 million in non-dilutive capital received, reducing near-term financing risk; $9.7 million in additional company investment
Risk Factors
- FDA clearance is not guaranteed and remains a key regulatory hurdle.
- Commercial adoption may be slow despite government support.
- Company must still contribute $9.7 million, which could pressure cash reserves if not offset by future funding.
Market Snapshot
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3258593 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Mar 24, 2026
11w ago
|
Press Release
| $1.54 $1.80 | ▲ +16.88% | ▲ +9.02% | $1.82 (+18.18%) |
|
Mar 18, 2026
12w ago
|
Press Release
| $1.42 $1.89 | ▲ +33.10% | ▲ +25.48% | $1.82 (+28.17%) |
|
Mar 10, 2026
13w ago
|
Press Release
| $1.40 $1.68 | ▲ +20.00% | ▲ +20.16% | $1.82 (+30.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access